期刊文献+

慢性压迫性脊髓症基质金属蛋白酶-9表达与血脊髓屏障破坏的相关性研究 被引量:3

The correlationship between MMP-9 expression and the blood-spinal cord barrier disruption in chronic compressive cervical myelopathy
原文传递
导出
摘要 目的 观察慢性压迫性脊髓症大鼠模型脊髓基质金属蛋白酶-9(matrix metalloproteinase-9,MMP-9)表达和血脊髓屏障(blood spinal cord barrier,BSCB)的变化,探讨二者相关性.方法 将48只成年SD大鼠随机分为假手术组和脊髓压迫组,每组各24只;将吸水后可膨胀聚氨酯薄板植入C5椎板下硬膜外,建立慢性压迫性脊髓症模型.造模后第4周,两组分别通过BBB(Basso Beattie Bresnahan)评分和体感诱发电位(somatosensory evoked potential,SEP)检测评价脊髓功能,每组各取12只行MMP-9、内皮屏障抗原(endothelial barrier antigen,EBA)免疫组化染色、检测二者在脊髓不同区域表达情况;其余12只行伊文思蓝(evans blue,EB)灌注检测BSCB通透性.统计学方法比较两组各观察指标差异,并分析脊髓压迫组MMP-9与EBA表达变化的相关性.结果 成功造模后第4周脊髓压迫组BBB评分显著低于假手术组;相对于假手术组,脊髓压迫组SEP检测潜伏期显著延长、波幅显著降低.脊髓压迫组白、灰质MMP-9表达均显著高于假手术组,脊髓压迫组灰质EBA表达显著低于假手术组,白质EBA表达无显著变化,脊髓压迫组EB含量显著高于假手术组;脊髓压迫组MMP-9表达与EBA表达半定量结果进行配对样本相关性分析显示两者呈显著相关(r=0.96,P=0.000).结论 慢性压迫性脊髓症大鼠模型建立第4周,脊髓功能显著降低,同时BSCB结构破坏、通透性增加,MMP-9表达增强并与EBA抗原显著减少显著相关,提示BSCB破坏可能与MMP-9表达显著增高相关. Objective To investigate the correlation between the expression of MMP-9 and the disruption of the blood spinal cord barrier (BSCB) in chronic cervical cord compressive myelopathy rat model.Methods 48 adult rats were randomly divided into group A (sham surgical group,n=24) and group B (spinal cord compressive group,n=24).A water-absorbing polymer sheet was implanted into the C5 epidural space on the posterolateral side to induce a chronic spinal cord compression model.BBB scores and SEP were collected 4 weeks after surgery.Expression of MMP-9 and endothelial barrier antigen (EBA) were detected immunohistochemically in different spinal cord areas of 12 rats in each group.The other 12 rats were performed with Evans blue (EB) perfusion to observe the permeability of BSCB.The results and the correlation between MMP-9 and EBA expression were analyzed.Results BBB score was lower in spinal cord compressive group than that of sham surgical group.Latency was delayed and amplitude was reduced significantly in spinal cord compressive group.Expression level of MMP-9 in spinal cord compressive group was significant higher than that in both grey matter and white matter in sham surgical group.In the contrary,EBA expression was obviously more in grey matter of sham surgical group than that in spinal cord compressive group,while it showed no significant change in white matter between the 2 groups.EB perfusion in sham surgical group was less than that in spinal cord compressive group.MMP-9 expression was correlated with EBA staining significantly.Conclusion Neurological function of spinal cord in the compression group was abnormal,with a marked decline 4 weeks after model made.The increased permeability and structural failure of BSCB in chronic spinal cord compression myelopathy,which was characterized and correlated with increment of MMP-9 expression and decrement of EBA expression concurrently.Disruption of BSCB may be correlated with distinct increasing expression of MMP-9.
出处 《中华骨科杂志》 CAS CSCD 北大核心 2015年第4期456-462,共7页 Chinese Journal of Orthopaedics
基金 国家自然科学基金资助项目(81450020) 广东省自然科学基金项目(S2013010015778)
关键词 脊髓压迫症 大鼠 基质金属蛋白酶9 Matrix METALLOPROTEINASE 9 Spinal cord compression Rats
  • 相关文献

参考文献26

  • 1Fehlings MG, Jha NK, Hewson SM, et al. Is surgezy for cervical spondylotic myelopathy cost- effective? A cost- utility analysis based on data from the AOSpine North America prospective CSM study[J]. J Neurosurg Spine, 2012, 17(1 Sappl): 89-93.
  • 2Tracy JA, Bartleson JD. Cervical spondylotic myelopathy[J]. Neu- rologist, 2010, 16(3): 176-187.
  • 3党耕町,刘忠军.无症状颈椎退变性脊髓压迫——对一种亚临床状态的思考[J].中国脊柱脊髓杂志,2009,19(1):5-7. 被引量:16
  • 4Kalsi-Ryan S, Karadimas SK, Fehlings MG. Cervical spondylotie myelopathy: the clinical phenomenon and the current pathobiolo- gy of an increasingly prevalent and devastating disorder [J ]. Neu- roseientist, 2013, 19(4): 409-421.
  • 5Muoio V, Persson PB, Sendeski MM. The neurovascular unit -con- cept review [ J ]. Aeta Physiol (Oxf), 210(4): 790-798.
  • 6Bartanusz V, Jezova D, Alajajian B, et al. The blood-spinal cord barrier: morphology and clinical implications [J]. Ann Neurol,2011, 70(2): 194-206.
  • 7Figley SA, Khosravi R, Legasto JM, et al. Characterization of vas- cular disruption and blood-spinal cord barrier permeability follow- ing traumatic spinal cord injury[J]. J Neurotrauma, 2014, 31(6): 541-552.
  • 8Jacobs TP, Kempski O, McKinley D, et al. Blood flow and vascu- lar permeability during motor dysfunction in a rabbit model of spi- nal cord ischemia[J]. Stroke, 1992, 23(3): 367-373.
  • 9Garbuzova-Davis S, Hernandez-Ontiveros DG, Rodrigues MC, et al. Impaired blood-brain/spinal cord barrier in ALS patients [J]. Brain Res, 2012, 1469: 114-128.
  • 10Karadimas SK, Moon ES, Yu WR, et al. A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate trans- lational research[J]. Neurobiol Dis, 2013, 54: 43-58.

二级参考文献18

  • 1第二届颈椎病专题座谈会纪要[J].中华外科杂志,1993,31(8):472-476. 被引量:2441
  • 2McCormick WE,Steinmetz MP,Benzel EC.Cervical spondylotic myelopathy:make the difficult diagnosis,then refer for surgery.Cleve Clin J Med,2003,70(10):899-904.
  • 3Ichihara K,Tagnchi T,Sakuramoto I,et al.Mechanism of the spinal cord injury and the cervical spondylotic myelopathy:new approach based on the mechanical features of the spinal cord white and gray matter.J Neurosurg 2003,99(3 Suppl):278-285.
  • 4Rao R.Neck pain,cervical radiculopathy,and cervical myelopathy:pathophysiology,natural history,and clinical evaluation.J Bone Joint Surg (Am),2002,84(10):1872-1881.
  • 5Baron EM,Young WF.Cervical spondylotic myelopathy:a brief review of its pathophysiology,clinical course,and diagnosis.Nearosurgery,2007,60(1 Suppl 1):S35-41.
  • 6Hu Y,Jiang F,Luk KD.Time-frequency feature of intraoporative somatosensory evoked potential signals.Conf Proc IEEE Eng Med Biol Soc,2007,2007(24):2448-2451.
  • 7Bouchard JA,Bohlman HH,Biro C.Intraoporative improvements of somatosensory evoked potentials:correlation to clinical outcome in surgery for cervical spondylitic myelopathy.Spine (Phila Pa 1976),1996,21(5):589-594.
  • 8Hu Y,Ding Y,Ruan D,et al.Prognostic value of somatosensoryevoked potentials in the surgical management of cervical spondylotic myeiopathy.Spine (Phila Pa 1976),2008,33(10):E305-E310.
  • 9Zhang ZG,Yang JL Chan SC,et al.Time-frequency component analysis of sematesensory evoked potentials in rats.Biomed Eng Online,2009,8:4.
  • 10Cheung WY,Arvinte D,Wong YW,et al.Neurological recovery after surgical decompression in patients with cervical spondylotic myeiopathy-a prospective study.Int Orthop,2008,32 (2):273-278.

共引文献28

同被引文献26

  • 1Kalsi-Ryan S, Karadimas SK, Fehlings MG, et al. Cervical spond-ylotic myelopathy : the clinical phenomenon and the current pathob-iology of an increasingly prevalent and devastating disorder [J]. Ne-uroscientist, 2013,19(4) :409^21. DOI: 10.1177/1073858412467377.
  • 2Matz PG, Anderson PA, Holly LT, et al. The natural history ofcervical spondylotic myelopathy [J]. J Neurosurg Spine, 2009,11(2):104-111.DOI:10.3171/2009.1.SPINE08716.
  • 3Lebl DR, Hughes A, Ca mmisa FP, et al. Cervical spondylotic my-elopathy :pathophysiology, clinical presentation, and treatment [J].HSS J,2011,7(2): 170-178. DOI: 10.1007/sl 1420-011-9208-1.
  • 4Long HQ, Li GS, Lin EJ, et al. Is the speed of chronic compressionan important factor for chronic spinal cord injury rat model? [J].Neurosci Lett, 2013,545:75-80. DOI: 10.1016/j.neulet.2013.04.024.
  • 5Muoio V, Persson PB, Sendeski MM. The neurovascular unit-con-cept review [J]. Acta Physiol (Oxf),2014,210(4):790-798. DOI :10.11 ll/apha.12250.
  • 6Garbuzova-Davis S, Haller E, Saporta S, et al. Ultrastructure ofblood-brain barrier and blood-spinal cord barrier in S0D1 micemodeling ALS[J]. Brain Res, 2007,1157: 126-137. DOI: 10.1016/j.brainres. 2007.04.044.
  • 7Figley SA, Khosravi R, Legasto JM, et al. Characterization of vas-cular disruption and blood-spinal cord barrier permeability followingtraumatic spinal cord injury [J]. J Neurotrauma, 2014,31(6):541-552. DOI: 10.1089/neu.2013.3034.
  • 8Fang B, Li XM, Sun XJ, et al. Ischemic preconditioning protectsagainst spinal cord ischemia-reperfusion injury in rabbits by attenu-ating blood spinal cord barrier disruption [J]. Int J Mol Sci, 2013,14(5) : 10343-10354. DOI: 10.3390/ijmsl40510343.
  • 9Garbuzova-Davis S,Sanberg PR. Blood-CNS barrier impairment inALS patients versus an animal model [J]. Front Cell Neurosci, 2014,8:21. DOI: 10.3389/fncel.2014.00021.
  • 10Karadimas SK, Gatzounis G, Fehlings MG. Pathobiology of cervicalspondylotic myelopathy [J]. Eur Spine J,2015,24 Suppl 2:S132-S138. DOI: 10.1007/s00586-014-3264-4.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部